Exercise

Published Clinical Study Illustrates Benefits of Promentum Recover as Low-Dose Solution for Post Exercise Recovery

MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human clinical study demonstrates that Promentum® Recover, a patent-pending formula…

4 days ago

Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026

Press Release Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026April 20, 2026 – release at…

1 week ago

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

April 06, 2026 10:53 ET  | Source: Celldex Therapeutics, Inc. HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics,…

3 weeks ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

2 months ago

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

2 months ago

Manipal Hospital Whitefield Redefines Integrated Athlete Care with Launch of Sports & Exercise Science Hub

BENGALURU, India, Jan. 29, 2026 /PRNewswire/ -- Manipal Hospital Whitefield has marked a significant milestone in Sports Medicine with the…

3 months ago

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

January 23, 2026 17:00 ET  | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) --…

3 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

January 20, 2026 17:31 ET  | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics,…

3 months ago

DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA…

3 months ago

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million

SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

7 months ago